While precisionFDA does not serve a regulatory role, it is expected to generate knowledge to inform future regulatory pathways and decision making.
PrecisionFDA provides a private area where participants (individuals or organizations) can conduct genome analysis and comparison against reference material, and a community area where they can publish and share results, reference materials, and tools. The precisionFDA community continues to grow and includes:
- Genome Test or Software Providers
- Standards-making Bodies
- Pharmaceutical & Biotechnology Companies
- Healthcare Providers
- Academic Medical Centers
- FDA & Other Government Agencies
This program is in beta at this time.
For further information and to express interest in participating please submit our request access form.